149 related articles for article (PubMed ID: 32638626)
1. Recent advances in inhibitors of C-terminal SRC kinase.
P O'Malley D
Future Med Chem; 2020 Aug; 12(16):1447-1449. PubMed ID: 32638626
[No Abstract] [Full Text] [Related]
2. Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnerta H; Ungefroren H
Anticancer Agents Med Chem; 2017; 17(10):1351-1356. PubMed ID: 28044939
[TBL] [Abstract][Full Text] [Related]
3. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
[TBL] [Abstract][Full Text] [Related]
4. De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.
Urich R; Wishart G; Kiczun M; Richters A; Tidten-Luksch N; Rauh D; Sherborne B; Wyatt PG; Brenk R
ACS Chem Biol; 2013 May; 8(5):1044-52. PubMed ID: 23534475
[TBL] [Abstract][Full Text] [Related]
5. Irreversible inhibitors of c-Src kinase that target a nonconserved cysteine.
Kwarcinski FE; Fox CC; Steffey ME; Soellner MB
ACS Chem Biol; 2012 Nov; 7(11):1910-7. PubMed ID: 22928736
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in development of hetero-bivalent kinase inhibitors.
Lee S; Kim J; Jo J; Chang JW; Sim J; Yun H
Eur J Med Chem; 2021 Apr; 216():113318. PubMed ID: 33730624
[TBL] [Abstract][Full Text] [Related]
7. In vitro selection of a DNA-templated small-molecule library reveals a class of macrocyclic kinase inhibitors.
Kleiner RE; Dumelin CE; Tiu GC; Sakurai K; Liu DR
J Am Chem Soc; 2010 Aug; 132(33):11779-91. PubMed ID: 20681606
[TBL] [Abstract][Full Text] [Related]
8. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
Johnson TK; Soellner MB
Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
[TBL] [Abstract][Full Text] [Related]
9. Generation of Epithelial Cell Populations from Human Pluripotent Stem Cells Using a Small-Molecule Inhibitor of Src Family Kinases.
Selekman JA; Lian X; Palecek SP
Methods Mol Biol; 2016; 1307():319-27. PubMed ID: 24500899
[TBL] [Abstract][Full Text] [Related]
10. Small molecules-Giant leaps for immuno-oncology.
Kötzner L; Huck B; Garg S; Urbahns K
Prog Med Chem; 2020; 59():1-62. PubMed ID: 32362326
[TBL] [Abstract][Full Text] [Related]
11. Small-Molecule Inhibition of the UNC-Src Interaction Impairs Dynamic Src Localization in Cells.
Garivet G; Hofer W; Konitsiotis A; Klein C; Kaiser N; Mejuch T; Fansa E; Alsaabi R; Wittinghofer A; Bastiaens PIH; Waldmann H
Cell Chem Biol; 2019 Jun; 26(6):842-851.e7. PubMed ID: 30956149
[TBL] [Abstract][Full Text] [Related]
12. Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors.
Boschelli DH; Wang D; Wang Y; Wu B; Honores EE; Barrios Sosa AC; Chaudhary I; Golas J; Lucas J; Boschelli F
Bioorg Med Chem Lett; 2010 May; 20(9):2924-7. PubMed ID: 20363128
[TBL] [Abstract][Full Text] [Related]
13. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A
Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146
[TBL] [Abstract][Full Text] [Related]
14. Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.
Schoene J; Gazzi T; Lindemann P; Christmann M; Volkamer A; Nazaré M
ChemMedChem; 2019 Aug; 14(16):1514-1527. PubMed ID: 31264364
[TBL] [Abstract][Full Text] [Related]
15. Towards simple kinetic models of functional dynamics for a kinase subfamily.
Sultan MM; Kiss G; Pande VS
Nat Chem; 2018 Sep; 10(9):903-909. PubMed ID: 29988151
[TBL] [Abstract][Full Text] [Related]
16. SRC inhibitors as potential therapeutic agents for human cancers.
Trevino JG; Summy JM; Gallick GE
Mini Rev Med Chem; 2006 Jun; 6(6):681-7. PubMed ID: 16787379
[TBL] [Abstract][Full Text] [Related]
17. Novel patented SRC kinase inhibitor.
Lu XL; Liu XY; Cao X; Jiao BH
Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Inhibition of the UNC119-Cargo Interaction.
Mejuch T; Garivet G; Hofer W; Kaiser N; Fansa EK; Ehrt C; Koch O; Baumann M; Ziegler S; Wittinghofer A; Waldmann H
Angew Chem Int Ed Engl; 2017 May; 56(22):6181-6186. PubMed ID: 28471079
[TBL] [Abstract][Full Text] [Related]
19. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.
Chaudhary D; Robinson S; Romero DL
J Med Chem; 2015 Jan; 58(1):96-110. PubMed ID: 25479567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
